(2011) "Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function" Journal of Diabetes Research, 2011:279530 This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietician, and Lujain Alhassan, Bariatric Nutritionist, on 20 May 2025
The Power Duo: Mechanism and Targeted Effects The efficacy of this stack lies in the distinct but complementary functions of its individual components, both of which fall under the umbrella of Growth Hormone Releasing Peptides (and their analogs): CJC-1295 (GHRH Analog): As a Growth Hormone-Releasing Hormone (GHRH) analog, CJC-1295s primary role is to bind to GHRH receptors on the pituitary gland
DSIP tended to decrease awakenings, enhance sleep efficiency, reduce light sleep stages, and possibly increase REM sleep
We accept HSA and FSA payments, and provide detailed receipts for your records
Additionally, for type 2 diabetes patients with cardiovascular disease or chronic kidney disease, this medication can reduce the risk of cardiovascular events and the progression of kidney damage
Continue Your Research Making an informed decision about GLP-1 treatment means understanding all your options